What immune mechanism explains long-term protection even if antibody levels wane after vaccination?

What immune mechanism explains long-term protection even if antibody levels wane after vaccination?

• A. Direct continuous presence of antibodies in serum.
• B. Innate immune response only.
• C. Active during infection only.
• D. Persistent memory B and T cells that respond upon re-exposure.

Answer: (D)

Immunological memory is what provides long-term protection after vaccination even when antibody levels have declined. When you’re first vaccinated, B cells that recognize the pathogen become antibody-producing plasma cells and, importantly, form memory B cells that persist for years. T cells also develop memory populations. These memory cells sit quietly until they’re needed again. If the person is exposed to the pathogen later, memory B cells rapidly react by becoming plasma cells and flooding the system with antibodies, often at higher affinity and more quickly than after the first exposure. Memory T cells also respond faster, helping coordinate a rapid and effective attack on infected cells. Because of this ready-for-action memory, protection remains even though circulating antibodies may wane over time. The other ideas don’t explain the lasting protection. Continual presence of antibodies isn’t necessary if memory cells can quickly produce antibodies upon re-exposure. Relying on the innate immune response or on protection only during active infection doesn’t account for the durable, specific recall that memory B and T cells provide when the pathogen reappears.

Immunological memory is what provides long-term protection after vaccination even when antibody levels have declined. When you’re first vaccinated, B cells that recognize the pathogen become antibody-producing plasma cells and, importantly, form memory B cells that persist for years. T cells also develop memory populations. These memory cells sit quietly until they’re needed again. If the person is exposed to the pathogen later, memory B cells rapidly react by becoming plasma cells and flooding the system with antibodies, often at higher affinity and more quickly than after the first exposure. Memory T cells also respond faster, helping coordinate a rapid and effective attack on infected cells. Because of this ready-for-action memory, protection remains even though circulating antibodies may wane over time.

The other ideas don’t explain the lasting protection. Continual presence of antibodies isn’t necessary if memory cells can quickly produce antibodies upon re-exposure. Relying on the innate immune response or on protection only during active infection doesn’t account for the durable, specific recall that memory B and T cells provide when the pathogen reappears.